Concepedia

Magnus Petersson

MP

37

Publications

4.4K

Citations

23

H-Index

2002

Active since

Affiliations

University of Glasgow(Current)

Brigham and Women's Hospital

National University of Singapore

Yale University

Northwestern University

Magnus Petersson is an author at University of Glasgow specializing in cardiovascular disease, cardiovascular pharmacology, and cardiology.

ORCID

Top concepts

Publications per year

2002–2024

37

Publications

37

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Scott D. Solomon, John J.V. McMurray, Brian Claggett et al. · New England Journal of Medicine · 2022 · 2.4K citations · Full text

Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the <scp>DELIVER</scp> trial

Scott D. Solomon, Rudolf A. de Boer, David L. DeMets et al. · European Journal of Heart Failure · 2021 · 307 citations · Full text

Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction

Scott D. Solomon, Muthiah Vaduganathan, Brian Claggett et al. · JACC Heart Failure · 2022 · 155 citations · Full text

Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure

Magnus Petersson, Peter Friberg, Graeme Eisenhofer et al. · European Heart Journal · 2005 · 153 citations · Full text

Dapagliflozin for heart failure according to body mass index: the DELIVER trial

Carly Adamson, Toru Kondo, Pardeep S. Jhund et al. · European Heart Journal · 2022 · 140 citations · Full text

Rows per page

1–5 of 37